CD133 expression is associated with small round blue cell tumour morphology in human central nervous system neoplasms

Histopathology

Volumn 58, Issue 5, 2011, Pages 739-749

  Schittenhelm, Jens ^a   Simon, Perikles ^a,b   Harter, Patrick N ^c   Zachskorn, Cornelia ^c   Schlaszus, Holger ^a   Röttger, Frauke ^d   Winkels, Monika ^d   Weller, Michael ^e,f   Meyermann, Richard ^a   Mittelbronn, Michel ^a,c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d MILTENYI BIOTEC GMBH   (Germany)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

CD133; CNS neoplasms; Stem cells

Indexed keywords

CD133 ANTIGEN; CD15 ANTIGEN; NESTIN;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM TUMOR; CORRELATION ANALYSIS; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MORPHOLOGY; PRIORITY JOURNAL; STEM CELL;

ANTIGENS, CD; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; NEOPLASTIC STEM CELLS; NERVE TISSUE PROTEINS; PEPTIDES; PROTEIN ISOFORMS;

ANIMALIA;

EID: 79954589236     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03801.x     Document Type: Article

References (55)

1. Terrin BN, Studer EJ, Wood N, Mohanakumar T, Russell EC. Childhood leukemia with simultaneously expressed myeloid and lymphoid markers suggesting stem cell origin. Am. J. Hematol. 1985; 20; 175-181.
2. Schulenburg A, Ulrich-Pur H, Thurnher D et al. Neoplastic stem cells: a novel therapeutic target in clinical oncology. Cancer 2006; 107; 2512-2520.
3. Burkert J, Wright NA, Alison MR. Stem cells and cancer: an intimate relationship. J. Pathol. 2006; 209; 287-297.
4. Uchida N, Buck DW, He D et al. Direct isolation of human central nervous system stem cells. Proc. Natl Acad. Sci. USA 2000; 97; 14720-14725.
5. Gritti A, Frolichstahl-Schoeller P, Galli R et al. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J. Neurosci. 1999; 19; 3287-3297.
6. Richardson RM, Fillmore HL, Holloway KL, Broaddus WC. Progress in cerebral transplantation of expanded neuronal stem cells. J. Neurosurg. 2004; 100; 659-671.
7. Fargeas CA, Joester A, Missol-Kolka E et al. Identification of novel Prominin-1/CD133 splice variants with alternative C-termini and their expression in epididymis and testis. J. Cell Sci. 2004; 117; 4301-4311.
8. Frank NY, Margaryan A, Huang Y et al. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 2005; 65; 4320-4333.
9. Padovan CS, Jahn K, Birnbaum T et al. Expression of neuronal markers in differentiated marrow stromal cells and CD133+ stem-like cells. Cell Transplant. 2003; 12; 839-848.
10. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445; 111-115.
11. Lee A, Kessler JD, Read TA et al. Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci. 2005; 8; 723-729.
12. Yu Y, Flint A, Dvorin EL, Bischoff J. AC133-2, a novel isoform of human AC133 stem cell antigen. J. Biol. Chem. 2002; 277; 20711-20716.
13. Bidlungmeier S, Zhu X, Liu B. The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells. J. Mol. Med. 2008; 86; 1025-1032.
14. Klein WM, Wu BP, Zhao S, Wu H, Klein-Szanto AJ, Tahan SR. Increased expression of stem cell markers in malignant melanoma. Mod. Pathol. 2007; 20; 102-107.
15. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ. Prospective identification of tumourigenic prostate cancer stem cells. Cancer Res. 2005; 65; 10946-10951.
16. Bao S, Wu Q, McLendon RE et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444; 756-760.
17. Liu G, Yuan X, Zeng Z et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol. Cancer 2006; 5; 6.
18. Bruno S, Bussolati B, Grange C et al. CD133+ renal progenitor cells contribute to tumour angiogenesis. Am. J. Pathol. 2006; 169; 2223-2235.
19. Fan X, Matsui W, Khaki L et al. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumours. Cancer Res. 2006; 66; 7445-7452.
20. Schomig K, Busch G, Steppich B et al. Interleukin-8 is associated with circulating CD133+ progenitor cells in acute myocardial infarction. Eur. Heart J. 2006; 27; 1032-1037.
21. Brat DJ, Bellail AC, Van Meir EG. The role of interleukin-8 and its receptors in gliomagenesis and tumoural angiogenesis. Neuro Oncol. 2005; 7; 122-133.
22. Melnikova VO, Bar-Eli M. Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. Pigment Cell Res. 2006; 19; 395-405.
23. Tas F, Duranyildiz D, Oguz H, Camlica H, Yasasever V, Topuz E. Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancer. Cancer Invest. 2006; 24; 492-496.
24. Florek M, Bauer N, Janich P et al. Prominin-2 is a cholesterol-binding protein associated with apical and basolateral plasmalemmal protrusions in polarized epithelial cells and released into urine. Cell Tissue Res. 2007; 328; 31-47.
25. Lee CC, Ye F, Tarantal AF. Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. Stem Cells Dev. 2006; 15; 209-220.
26. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK(eds). Pathology and genetics of tumours of the central nervous system. Lyon: International Agency for Research on Cancer, 2007.
27. Simon P, Schott K, Williams RW, Schaeffel F. Posttranscriptional regulation of the immediate-early gene EGR1 by light in the mouse retina. Eur. J. Neurosci. 2004; 20; 3371-3377.
28. Simon P, Feldkaemper M, Bitzer M, Ohngemach S, Schaeffel F. Early transcriptional changes of retinal and choroidal TGFbeta-2, RALDH-2, and ZENK following imposed positive and negative defocus in chickens. Mol. Vis. 2004; 10; 588-597.
29. Simon P. Q-Gene: processing quantitative real-time RT-PCR data. Bioinformatics 2003; 19; 1439-1440.
30. Mittelbronn M, Capper D, Bunz B et al. Denovo erythropoietin receptor (EPO-R) expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survival. Neuropathol. Appl. Neurobiol. 2007; 33; 299-307.
31. Lapidot T, Sirard C, Vormoor J et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 1994; 367; 645-648.
32. Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121; 823-835.
33. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumourigenic breast cancer cells. Proc. Natl Acad. Sci. USA 2003; 100; 3983-3988.
34. Singh SK, Hawkins C, Clarke ID et al. Identification of human brain tumour initiating cells. Nature 2004; 432; 396-401.
35. Piccirillo SG, Reynolds BA, Zanetti N et al. Bone morphogenetic proteins inhibit the tumourigenic potential of human brain tumour-initiating cells. Nature 2007; 444; 761-765.
36. Blazek ER, Foutch JL, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133-cells, and the CD133+ sector is enlarged by hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 2007; 67; 1-5.
37. Salmaggi A, Boiardi A, Gelati M et al. Glioblastoma-derived tumourospheres identify a population of tumour stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype. Glia 2006; 54; 850-860.
38. Seigel GM, Hackam AS, Ganguly A, Mandell LM, Gonzalez-Fernandez F. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol. Vis. 2007; 13; 823-832.
39. Qiang L, Yang Y, Ma YJ et al. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines. Cancer Lett. 2009; 279; 13-21.
40. Beier D, Hau P, Proescholdt M et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 2007; 67; 4010-4015.
41. Liu Q, Nguyen DH, Dong Q et al. Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors. J. Neurooncol. 2009; 94; 1-19.
42. Clément V, Dutoit V, Marino D, Dietrich PY, Radovanovic I. Limits of CD133 as a marker of glioma self-renewing cells. Int. J. Cancer 2009; 125; 244-248.
43. Christensen K, Schrøder HD, Kristensen BW. CD133 identifies perivascular niches in grade II-IV astrocytomas. J. Neurooncol. 2008; 90; 157-170.
44. Ma YH, Mentlein R, Knerlich F, Kruse ML, Mehdorn HM, Held-Feindt J. Expression of stem cell markers in human astrocytomas of different WHO grades. J. Neurooncol. 2008; 86; 31-45.
45. Zeppernick F, Ahmadi R, Campos B et al. Stem cell marker CD133 affects clinical outcome in glioma patients. Clin. Cancer Res. 2008; 14; 123-129.
46. Ferrandina G, Bonanno G, Pierelli L et al. Expression of CD133-1 and CD133-2 in ovarian cancer. Int. J. Gynecol. Cancer 2008; 18; 506-514.
47. Wright MH, Calcagno AM, Salcido CD, Carlson MD, Ambudkar SV, Varticovski L. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics. Breast Cancer Res. 2008; 10; R10.
48. Ramalho-Santos M, Yoon S, Matsuzaki Y, Mulligan RC, Melton DA. Stemness: transcriptional profiling of embryonic and adult stem cells. Science 2002; 298; 597-600.
49. Lyden D, Hattori K, Dias S et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat. Med. 2001; 7; 1194-1201.
50. Calabrese C, Poppleton H, Kocak M et al. A perivascular niche for brain tumour stem cells. Cancer Cell 2008; 11; 69-82.
51. McCord AM, Jamal M, Shankavarum UT, Lang FF, Camphausen K, Tofilon PJ. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol. Cancer Res. 2009; 7; 489-497.
52. Platet N, Liu SY, Atifi ME et al. Influence of oxygen tension on CD133 phenotype in human glioma cell cultures. Cancer Lett. 2007; 258; 286-290.
53. Günther HS, Schmidt NO, Phillips HS et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 2008; 27; 2897-2909.
54. Taylor MD, Poppleton H, Fuller C et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005; 8; 323-335.
55. Nishide K, Nakatani Y, Kiyonari H, Kondo T. Glioblastoma formation from cell population depleted of Prominin1-expressing cells. PLoS ONE 2009; 4; e6869.